Medicare Spending was 27% More for People who Disenrolled from Medicare Advantage than Similar People in Traditional Medicare

This analysis looks at traditional Medicare spending among people who choose to disenroll from Medicare Advantage and obtain coverage under traditional Medicare during the annual Medicare open enrollment period. It compares their traditional Medicare spending (Parts A and B) in the year following disenrollment to similar people who were continuously covered by traditional Medicare, using…

Read More

Have we reached ‘peak HEOR’?

That is the title of my guest column at The Evidence Base. An excerpt is below: Multiple indicators suggest that health economics and outcomes research (HEOR) faces unprecedented challenges to its traditional role in pharmaceutical value demonstration. Yet these apparent threats may signal evolution rather than decline – if the field can adapt to serve…

Read More

Moving Beyond the Mega-Factory: Why the Future of Biomanufacturing is Agile, Distributed, and Resilient

Personalized and highly-targeted therapeutics are becoming more common, making local or regional production increasingly valuable for faster patient access. This underscores how a hybrid network combining large, centralized plants coupled with flexible regional sites will define the next era of resilient biomanufacturing. The post Moving Beyond the Mega-Factory: Why the Future of Biomanufacturing is Agile,…

Read More